Guideline | Drug Name |
---|---|
Rezdiffra (resmetirom) - PA, NF | Rezdiffra (resmetirom) |
Rezlidhia (olutasidenib) - PA, NF | Rezlidhia (olutasidenib) |
Rezurock (belumosudil) - PA, NF | Rezurock (belumosudil) |
Rezzayo (rezafungin) | Rezzayo (rezafungin) |
Riluzole Products - PA, NF | Exservan (riluzole film), Rilutek (riluzole tablets), Tiglutik (riluzole suspension), Teglutik (riluzole suspension) |
Rinvoq (upadacitinib) | Rinvoq (upadacitinib) ER tablets, Rinvoq LQ (upadacitinib) oral solution, Rinvoq (upadacitinib) extended-release (ER) tablets |
Rituxan Hycela (rituximab and hyaluronidase human) | Rituxan Hycela (rituximab and hyaluronidase human) |
Rituximab - PA, NF | Riabni (rituximab-arrx), Rituxan (rituximab), Ruxience (rituximab-pvvr), Truxima (rituximab-abbs) |
Rivfloza (nedosiran) | Rivfloza (nedosiran) |
Roctavian (valoctocogene roxaparvovec-rvox) | Roctavian (valoctocogene roxaparvovec-rvox) |
Roszet (rosuvastatin/ezetimibe) - ST, NF | Roszet (rosuvastatin/ezetimibe) |
Rozlytrek (entrectinib) | Rozlytrek (entrectinib) |
Rubraca (rucaparib) - PA, NF | Rubraca (rucaparib) |
Rybrevant (amivantamab) | Rybrevant (amivantamab) |
Rydapt (midostaurin) | Rydapt (midostaurin) capsules |
Ryplazim (plasminogen, human-tvmh) | Ryplazim (plasminogen, human-tvmh) |
Rystiggo (rozanolixizumab) | Rystiggo (rozanolixizumab) |
Rytelo (imetelstat) | Rytelo (imetelstat) |
Sabril, Vigadrone, Vigafyde (vigabatrin) | Sabril (vigabatrin), Vigadrone (vigabatrin), Vigafyde (vigabatrin) |
Saphnelo (anifrolumab-fnia) | Saphnelo (anifrolumab-fnia) |